Injectable In-Situ Crosslinked Hydrogel And The Preparation Method And Use Thereof

Patent No. EP2353612 (titled "Injectable In-Situ Crosslinked Hydrogel And The Preparation Method And Use Thereof") was filed by Bioregen Biomedical Changzhou on Sep 8, 2009. The application was issued on Jan 3, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
CROMA PHARMA GESELLSCHAFTOct 3, 2018SCHWARZ & PARTNER PATENTANWALTE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2353612

BIOREGEN BIOMEDICAL CHANGZHOU
Application Number
EP09820182A
Filing Date
Sep 8, 2009
Status
Opposition Rejected
Sep 15, 2023
Publication Date
Jan 3, 2018